Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Uncovering educator perspectives of occupation-centred education in Australia: A qualitative study.

Di Tommaso A, Wicks A, Scarvell J, Isbel S.

Aust Occup Ther J. 2019 Apr;66(2):174-182. doi: 10.1111/1440-1630.12529. Epub 2018 Sep 28.

PMID:
30264521
2.

NOTCH and Graft-Versus-Host Disease.

Di Ianni M, Del Papa B, Baldoni S, Di Tommaso A, Fabi B, Rosati E, Natale A, Santarone S, Olioso P, Papalinetti G, Giancola R, Accorsi P, Di Bartolomeo P, Sportoletti P, Falzetti F.

Front Immunol. 2018 Aug 10;9:1825. doi: 10.3389/fimmu.2018.01825. eCollection 2018. Review.

3.

Primary Contact Occupational Therapy Hand Clinics: The pull of an occupational perspective.

Burley S, Cox R, Di Tommaso A, Molineux M.

Aust Occup Ther J. 2018 Dec;65(6):533-543. doi: 10.1111/1440-1630.12507. Epub 2018 Aug 22.

PMID:
30132914
4.

NOTCH1 Is Aberrantly Activated in Chronic Lymphocytic Leukemia Hematopoietic Stem Cells.

Di Ianni M, Baldoni S, Del Papa B, Aureli P, Dorillo E, De Falco F, Albi E, Varasano E, Di Tommaso A, Giancola R, Accorsi P, Rotta G, Rompietti C, Silva Barcelos EC, Campese AF, Di Bartolomeo P, Screpanti I, Rosati E, Falzetti F, Sportoletti P.

Front Oncol. 2018 Apr 20;8:105. doi: 10.3389/fonc.2018.00105. eCollection 2018.

5.

Targeted Delivery of Toxoplasma gondii Antigens to Dendritic Cells Promote Immunogenicity and Protective Efficiency against Toxoplasmosis.

Lakhrif Z, Moreau A, Hérault B, Di-Tommaso A, Juste M, Moiré N, Dimier-Poisson I, Mévélec MN, Aubrey N.

Front Immunol. 2018 Feb 20;9:317. doi: 10.3389/fimmu.2018.00317. eCollection 2018.

6.

Bepridil exhibits anti-leukemic activity associated with NOTCH1 pathway inhibition in chronic lymphocytic leukemia.

Baldoni S, Del Papa B, Dorillo E, Aureli P, De Falco F, Rompietti C, Sorcini D, Varasano E, Cecchini D, Zei T, Di Tommaso A, Rosati E, Alexe G, Roti G, Stegmaier K, Di Ianni M, Falzetti F, Sportoletti P.

Int J Cancer. 2018 Aug 15;143(4):958-970. doi: 10.1002/ijc.31355. Epub 2018 Mar 23.

7.

Treg-protected donor lymphocyte infusions: a new tool to address the graft-versus-leukemia effect in the absence of graft-versus-host disease in patients relapsed after HSCT.

Di Ianni M, Olioso P, Giancola R, Santarone S, Natale A, Papalinetti G, Villanova I, Baldoni S, Di Tommaso A, Bonfini T, Accorsi P, Di Bartolomeo P.

Int J Hematol. 2017 Dec;106(6):860-864. doi: 10.1007/s12185-017-2292-3. Epub 2017 Jul 18.

PMID:
28721499
8.

Occupational therapists' perceptions of occupation in practice: An exploratory study.

Di Tommaso A, Isbel S, Scarvell J, Wicks A.

Aust Occup Ther J. 2016 Jun;63(3):206-13. doi: 10.1111/1440-1630.12289. Epub 2016 Apr 26.

PMID:
27116946
9.

Use of benzylglycinamide by a HIV-seropositive polysubstance user: The changing pattern of novel psychoactive substance use among youths.

Caloro M, Calabrò G, Kotzalidis GD, Cuomo I, Corkery JM, Vento AE, Lionetto L, De Filippis S, Ranieri V, Lonati D, Locatelli CA, de Pisa E, Di Tommaso A, Girardi P, Schifano F.

Addict Behav. 2016 Sep;60:53-7. doi: 10.1016/j.addbeh.2016.03.032. Epub 2016 Apr 6.

PMID:
27088514
10.

A method to confer Protein L binding ability to any antibody fragment.

Lakhrif Z, Pugnière M, Henriquet C, di Tommaso A, Dimier-Poisson I, Billiald P, Juste MO, Aubrey N.

MAbs. 2016;8(2):379-88. doi: 10.1080/19420862.2015.1116657. Epub 2015 Dec 18.

11.

Engineering venom's toxin-neutralizing antibody fragments and its therapeutic potential.

Alvarenga LM, Zahid M, di Tommaso A, Juste MO, Aubrey N, Billiald P, Muzard J.

Toxins (Basel). 2014 Aug 21;6(8):2541-67. doi: 10.3390/toxins6082541. Review.

12.

A revised NOTCH1 mutation frequency still impacts survival while the allele burden predicts early progression in chronic lymphocytic leukemia.

Sportoletti P, Baldoni S, Del Papa B, Aureli P, Dorillo E, Ruggeri L, Plebani S, Amico V, Di Tommaso A, Rosati E, Marconi P, Di Ianni M, Falzetti F.

Leukemia. 2014 Feb;28(2):436-9. doi: 10.1038/leu.2013.289. Epub 2013 Oct 9. No abstract available.

PMID:
24177259
13.

A novel, non-canonical splice variant of the Ikaros gene is aberrantly expressed in B-cell lymphoproliferative disorders.

Capece D, Zazzeroni F, Mancarelli MM, Verzella D, Fischietti M, Di Tommaso A, Maccarone R, Plebani S, Di Ianni M, Gulino A, Alesse E.

PLoS One. 2013 Jul 9;8(7):e68080. doi: 10.1371/journal.pone.0068080. Print 2013.

14.

ATIP3, a novel prognostic marker of breast cancer patient survival, limits cancer cell migration and slows metastatic progression by regulating microtubule dynamics.

Molina A, Velot L, Ghouinem L, Abdelkarim M, Bouchet BP, Luissint AC, Bouhlel I, Morel M, Sapharikas E, Di Tommaso A, Honoré S, Braguer D, Gruel N, Vincent-Salomon A, Delattre O, Sigal-Zafrani B, André F, Terris B, Akhmanova A, Di Benedetto M, Nahmias C, Rodrigues-Ferreira S.

Cancer Res. 2013 May 1;73(9):2905-15. doi: 10.1158/0008-5472.CAN-12-3565. Epub 2013 Feb 8.

15.

Angiotensin II facilitates breast cancer cell migration and metastasis.

Rodrigues-Ferreira S, Abdelkarim M, Dillenburg-Pilla P, Luissint AC, di-Tommaso A, Deshayes F, Pontes CL, Molina A, Cagnard N, Letourneur F, Morel M, Reis RI, Casarini DE, Terris B, Couraud PO, Costa-Neto CM, Di Benedetto M, Nahmias C.

PLoS One. 2012;7(4):e35667. doi: 10.1371/journal.pone.0035667. Epub 2012 Apr 20.

16.

Design of mid-infrared amplifiers based on fiber taper coupling to erbium-doped microspherical resonator.

Mescia L, Bia P, De Sario M, Di Tommaso A, Prudenzano F.

Opt Express. 2012 Mar 26;20(7):7616-29. doi: 10.1364/OE.20.007616.

PMID:
22453441
17.

Diabody mixture providing full protection against experimental scorpion envenoming with crude Androctonus australis venom.

di Tommaso A, Juste MO, Martin-Eauclaire MF, Dimier-Poisson I, Billiald P, Aubrey N.

J Biol Chem. 2012 Apr 20;287(17):14149-56. doi: 10.1074/jbc.M112.348912. Epub 2012 Feb 28.

18.

[ATIP, a novel superfamily of microtubule-associated proteins].

Molina A, Rodrigues-Ferreira S, Di Tommaso A, Nahmias C.

Med Sci (Paris). 2011 Mar;27(3):244-6. doi: 10.1051/medsci/2011273244. Epub 2011 Mar 30. French. No abstract available.

19.

NOTCH1 PEST domain mutation is an adverse prognostic factor in B-CLL.

Sportoletti P, Baldoni S, Cavalli L, Del Papa B, Bonifacio E, Ciurnelli R, Bell AS, Di Tommaso A, Rosati E, Crescenzi B, Mecucci C, Screpanti I, Marconi P, Martelli MF, Di Ianni M, Falzetti F.

Br J Haematol. 2010 Nov;151(4):404-6. doi: 10.1111/j.1365-2141.2010.08368.x. Epub 2010 Aug 31. No abstract available.

PMID:
20813007
20.

8p22 MTUS1 gene product ATIP3 is a novel anti-mitotic protein underexpressed in invasive breast carcinoma of poor prognosis.

Rodrigues-Ferreira S, Di Tommaso A, Dimitrov A, Cazaubon S, Gruel N, Colasson H, Nicolas A, Chaverot N, Molinié V, Reyal F, Sigal-Zafrani B, Terris B, Delattre O, Radvanyi F, Perez F, Vincent-Salomon A, Nahmias C.

PLoS One. 2009 Oct 1;4(10):e7239. doi: 10.1371/journal.pone.0007239.

21.

Residues in the alternative reading frame tumor suppressor that influence its stability and p53-independent activities.

di Tommaso A, Hagen J, Tompkins V, Muniz V, Dudakovic A, Kitzis A, Ladeveze V, Quelle DE.

Exp Cell Res. 2009 Apr 15;315(7):1326-35. doi: 10.1016/j.yexcr.2009.01.010. Epub 2009 Jan 27.

22.

A novel nuclear interactor of ARF and MDM2 (NIAM) that maintains chromosomal stability.

Tompkins VS, Hagen J, Frazier AA, Lushnikova T, Fitzgerald MP, di Tommaso A, Ladeveze V, Domann FE, Eischen CM, Quelle DE.

J Biol Chem. 2007 Jan 12;282(2):1322-33. Epub 2006 Nov 16.

23.

Spinophilin: from partners to functions.

Sarrouilhe D, di Tommaso A, Métayé T, Ladeveze V.

Biochimie. 2006 Sep;88(9):1099-113. Epub 2006 May 17. Review.

PMID:
16737766
24.

Cyclosporine A and NAC on the inducible nitric oxide synthase expression and nitric oxide synthesis in rat renal artery cultured cells.

Lessio C, de Assunção Silva F, Glória MA, Di Tommaso AB, Gori Mouro M, Di Marco GS, Schor N, Higa EM.

Kidney Int. 2005 Dec;68(6):2508-16.

25.

The ink4a/arf locus evolution in primates: characterization of three ARF sequences.

Di Tommaso A, Soler C, Roos C, Kitzis A, Ladeveze V.

DNA Cell Biol. 2004 Mar;23(3):167-73.

PMID:
15068586
26.

Occupational risk of blood-borne viruses in healthcare workers: a 5-year surveillance program.

Baldo V, Floreani A, Dal Vecchio L, Cristofoletti M, Carletti M, Majori S, Di Tommaso A, Trivello R.

Infect Control Hosp Epidemiol. 2002 Jun;23(6):325-7.

PMID:
12083236
27.

Rationally designed strings of promiscuous CD4(+) T cell epitopes provide help to Haemophilus influenzae type b oligosaccharide: a model for new conjugate vaccines.

Falugi F, Petracca R, Mariani M, Luzzi E, Mancianti S, Carinci V, Melli ML, Finco O, Wack A, Di Tommaso A, De Magistris MT, Costantino P, Del Giudice G, Abrignani S, Rappuoli R, Grandi G.

Eur J Immunol. 2001 Dec;31(12):3816-24.

28.

The comparison of the effect of LTR72 and MF59 adjuvants on mouse humoral response to intranasal immunisation with human papillomavirus type 6b (HPV-6b) virus-like particles.

Greer CE, Petracca R, Buonamassa DT, Di Tommaso A, Gervase B, Reeve RL, Ugozzoli M, Van Nest G, De Magistris MT, Bensi G.

Vaccine. 2000 Dec 8;19(9-10):1008-12.

PMID:
11137233
29.

Influenza vaccines: antibody responses to split virus and MF59-adjuvanted subunit virus in an adult population.

Menegon T, Baldo V, Bonello C, Dalla Costa D, Di Tommaso A, Trivello R.

Eur J Epidemiol. 1999 Jul;15(6):573-6.

PMID:
10485352
30.

Zonula occludens toxin is a powerful mucosal adjuvant for intranasally delivered antigens.

Marinaro M, Di Tommaso A, Uzzau S, Fasano A, De Magistris MT.

Infect Immun. 1999 Mar;67(3):1287-91.

31.

Therapeutic intragastric vaccination against Helicobacter pylori in mice eradicates an otherwise chronic infection and confers protection against reinfection.

Ghiara P, Rossi M, Marchetti M, Di Tommaso A, Vindigni C, Ciampolini F, Covacci A, Telford JL, De Magistris MT, Pizza M, Rappuoli R, Del Giudice G.

Infect Immun. 1997 Dec;65(12):4996-5002.

32.

Acellular pertussis vaccines containing genetically detoxified pertussis toxin induce long-lasting humoral and cellular responses in adults.

Di Tommaso A, Bartalini M, Peppoloni S, Podda A, Rappuoli R, De Magistris MT.

Vaccine. 1997 Aug;15(11):1218-24.

PMID:
9286047
33.

[Work and maternity: the perception pf work risk and the incomplete application of the law that protects maternity].

Agnesi R, Valentini F, Dal Vecchio L, Meneghetti M, Di Tommaso A.

Epidemiol Prev. 1996 Apr-Sep;20(2-3):211-3. Italian. No abstract available.

PMID:
8766327
34.

Induction of antigen-specific antibodies in vaginal secretions by using a nontoxic mutant of heat-labile enterotoxin as a mucosal adjuvant.

Di Tommaso A, Saletti G, Pizza M, Rappuoli R, Dougan G, Abrignani S, Douce G, De Magistris MT.

Infect Immun. 1996 Mar;64(3):974-9.

35.

Helicobacter pylori-specific CD4+ T-cell clones from peripheral blood and gastric biopsies.

Di Tommaso A, Xiang Z, Bugnoli M, Pileri P, Figura N, Bayeli PF, Rappuoli R, Abrignani S, De Magistris MT.

Infect Immun. 1995 Mar;63(3):1102-6.

36.

Formaldehyde treatment of proteins can constrain presentation to T cells by limiting antigen processing.

di Tommaso A, de Magistris MT, Bugnoli M, Marsili I, Rappuoli R, Abrignani S.

Infect Immun. 1994 May;62(5):1830-4.

37.
38.

Interaction of the pertussis toxin peptide containing residues 30-42 with DR1 and the T-cell receptors of 12 human T-cell clones.

De Magistris MT, Di Tommaso A, Domenighini M, Censini S, Tagliabue A, Oksenberg JR, Steinman L, Judd AK, O'Sullivan D, Rappuoli R.

Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):2990-4.

39.

Phase I clinical trial of an acellular pertussis vaccine composed of genetically detoxified pertussis toxin combined with FHA and 69 kDa.

Podda A, Nencioni L, Marsili I, Peppoloni S, Volpini G, Donati D, Di Tommaso A, De Magistris MT, Rappuoli R.

Vaccine. 1991 Oct;9(10):741-5.

PMID:
1759492
40.

Lymphokine secretion and cytotoxic activity of human CD4+ T-cell clones against Bordetella pertussis.

Peppoloni S, Nencioni L, Di Tommaso A, Tagliabue A, Parronchi P, Romagnani S, Rappuoli R, De Magistris MT.

Infect Immun. 1991 Oct;59(10):3768-73.

41.

Identification of subregions of Bordetella pertussis filamentous hemagglutinin that stimulate human T-cell responses.

Di Tommaso A, Domenighini M, Bugnoli M, Tagliabue A, Rappuoli R, De Magistris MT.

Infect Immun. 1991 Sep;59(9):3313-5.

42.

Metabolic, humoral, and cellular responses in adult volunteers immunized with the genetically inactivated pertussis toxin mutant PT-9K/129G.

Podda A, Nencioni L, De Magistris MT, Di Tommaso A, Bossù P, Nuti S, Pileri P, Peppoloni S, Bugnoli M, Ruggiero P, et al.

J Exp Med. 1990 Sep 1;172(3):861-8.

43.

Characterization of genetically inactivated pertussis toxin mutants: candidates for a new vaccine against whooping cough.

Nencioni L, Pizza M, Bugnoli M, De Magistris T, Di Tommaso A, Giovannoni F, Manetti R, Marsili I, Matteucci G, Nucci D, et al.

Infect Immun. 1990 May;58(5):1308-15.

44.

[Quantitative and functional assay of AT III in neoplastic pathology].

Padoan AM, Di Tommaso A, Zerbinati C, Nascimeni O, Della Giustina L, Padovan L, Papaccio G, Tenchini P.

Chir Ital. 1985 Jun;37(3):250-62. Italian.

PMID:
4053245
45.

[Blood coagulation in 222 cases of solid malignant neoplasms].

Padoan AM, Di Tommaso A, Zerbinati C, Lo Monaco I, Nascimbeni O, Della Giustina L, Padovan L, Papaccio G, Tenchini P.

Chir Ital. 1985 Feb;37(1):3-16. Italian.

PMID:
3995662

Supplemental Content

Loading ...
Support Center